|
|
Volumn 9, Issue 1, 2009, Pages 37-39
|
|
European pharmaceutical pricing and reimbursement conference
a
a
NONE
(United States)
|
|
Author keywords
Orphan drug; Pricing; Reimbursement; Risk sharing; Value based pricing
|
|
Indexed keywords
CONFERENCE PAPER;
COST BENEFIT ANALYSIS;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG MARKETING;
FINANCIAL MANAGEMENT;
GOVERNMENT REGULATION;
PRIVATE HEALTH INSURANCE;
PROSPECTIVE PRICING;
PUBLIC HEALTH INSURANCE;
REIMBURSEMENT;
DRUG INDUSTRY;
DRUG MANUFACTURE;
ECONOMICS;
EUROPE;
HUMAN;
LEGAL ASPECT;
RISK MANAGEMENT;
DRUG COSTS;
DRUG INDUSTRY;
EUROPE;
HUMANS;
INSURANCE, HEALTH, REIMBURSEMENT;
ORPHAN DRUG PRODUCTION;
RISK SHARING, FINANCIAL;
|
|
EID: 68349143374
PISSN: 14737167
EISSN: 17448379
Source Type: Journal
DOI: 10.1586/14737167.9.1.37 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (0)
|
